Loading data
CRMNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 41.53 bn USD | 37.9 bn USD | 34.86 bn USD | 31.35 bn USD | 26.49 bn USD |
| Cost of revenue | 9.27 bn USD | 8.64 bn USD | 8.54 bn USD | 8.36 bn USD | 7.03 bn USD |
| Gross profit | 32.26 bn USD | 29.25 bn USD | 26.32 bn USD | 22.99 bn USD | 19.47 bn USD |
| Research and development expense | 5.99 bn USD | 5.49 bn USD | 4.91 bn USD | 5.06 bn USD | 4.47 bn USD |
| Operating profit | 8.33 bn USD | 7.21 bn USD | 5.01 bn USD | 1.03 bn USD | 548 m USD |
| Profit before tax | 9.52 bn USD | 7.44 bn USD | 4.95 bn USD | 660 m USD | 1.53 bn USD |
| Income tax expense | 2.06 bn USD | 1.24 bn USD | 814 m USD | 452 m USD | 88 m USD |
| Net income (reported basis) | 7.46 bn USD | 6.2 bn USD | 4.14 bn USD | 208 m USD | 1.44 bn USD |
| Basic earnings per share | 7.85 USD/share | 6.44 USD/share | 4.25 USD/share | 0.21 USD/share | 1.51 USD/share |
| Diluted earnings per share | 7.8 USD/share | 6.36 USD/share | 4.2 USD/share | 0.21 USD/share | 1.48 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.